JPS568312A - Amino acid pharmaceutical preparation - Google Patents
Amino acid pharmaceutical preparationInfo
- Publication number
- JPS568312A JPS568312A JP8453679A JP8453679A JPS568312A JP S568312 A JPS568312 A JP S568312A JP 8453679 A JP8453679 A JP 8453679A JP 8453679 A JP8453679 A JP 8453679A JP S568312 A JPS568312 A JP S568312A
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- amino
- lof
- tyrosine
- acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001413 amino acids Chemical class 0.000 title abstract 4
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 4
- 229940024606 amino acid Drugs 0.000 abstract 3
- 235000001014 amino acid Nutrition 0.000 abstract 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 abstract 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 2
- 229960004441 tyrosine Drugs 0.000 abstract 2
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 abstract 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 abstract 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 abstract 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 abstract 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 abstract 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- 229930064664 L-arginine Natural products 0.000 abstract 1
- 235000014852 L-arginine Nutrition 0.000 abstract 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 abstract 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
- 229930182844 L-isoleucine Natural products 0.000 abstract 1
- 239000004395 L-leucine Substances 0.000 abstract 1
- 235000019454 L-leucine Nutrition 0.000 abstract 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- 229930195722 L-methionine Natural products 0.000 abstract 1
- 229930182821 L-proline Natural products 0.000 abstract 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 abstract 1
- 239000004473 Threonine Substances 0.000 abstract 1
- 229960003767 alanine Drugs 0.000 abstract 1
- 229960005261 aspartic acid Drugs 0.000 abstract 1
- 235000020776 essential amino acid Nutrition 0.000 abstract 1
- 239000003797 essential amino acid Substances 0.000 abstract 1
- 229960002989 glutamic acid Drugs 0.000 abstract 1
- 229960002885 histidine Drugs 0.000 abstract 1
- 230000009545 invasion Effects 0.000 abstract 1
- 229960000310 isoleucine Drugs 0.000 abstract 1
- 229960003136 leucine Drugs 0.000 abstract 1
- 229960004452 methionine Drugs 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 229960003104 ornithine Drugs 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 229960002429 proline Drugs 0.000 abstract 1
- 229960001153 serine Drugs 0.000 abstract 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 abstract 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 abstract 1
- 229960002898 threonine Drugs 0.000 abstract 1
- 229960004295 valine Drugs 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8453679A JPS568312A (en) | 1979-07-03 | 1979-07-03 | Amino acid pharmaceutical preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8453679A JPS568312A (en) | 1979-07-03 | 1979-07-03 | Amino acid pharmaceutical preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS568312A true JPS568312A (en) | 1981-01-28 |
| JPH0116809B2 JPH0116809B2 (cs) | 1989-03-27 |
Family
ID=13833356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8453679A Granted JPS568312A (en) | 1979-07-03 | 1979-07-03 | Amino acid pharmaceutical preparation |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS568312A (cs) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5681515A (en) * | 1979-12-07 | 1981-07-03 | Tanabe Seiyaku Co Ltd | Amino acid transfusion |
| JPS58126767A (ja) * | 1982-01-22 | 1983-07-28 | Ajinomoto Co Inc | 肝臓病患者用栄養組成物 |
| JPS5916817A (ja) * | 1982-07-16 | 1984-01-28 | Eisai Co Ltd | アミノ酸輸液 |
| JPS5927817A (ja) * | 1982-08-05 | 1984-02-14 | Tanabe Seiyaku Co Ltd | アミノ酸輸液 |
| JPS59500966A (ja) * | 1982-05-17 | 1984-05-31 | ザ・トラステイ−ズ・オブ・コロンビア・ユニヴア−シテイ・イン・ザ・シテイ・オブ・ニユ−・ヨ−ク | 栄養輸液用アミノ酸溶液、その調製法及び使用法 |
| JPS6483017A (en) * | 1987-09-22 | 1989-03-28 | Morishita Pharma | Amino acid pharmaceutical for patient suffering from hepatic insufficiency |
| JPH0867628A (ja) * | 1994-06-23 | 1996-03-12 | Chugai Pharmaceut Co Ltd | 肝再生用治療剤 |
| EP1044017A1 (en) * | 1998-01-05 | 2000-10-18 | John Hopkins University School of Medicine | Supplement for dialysis patients |
| JP2002275059A (ja) * | 2001-03-15 | 2002-09-25 | Inst Of Physical & Chemical Res | 腎機能障害改善用アミノ酸組成物 |
| WO2002074302A1 (fr) * | 2001-03-15 | 2002-09-26 | Riken | Compositions d'acides amines utilisees pour ameliorer l'insuffisance hepatique |
| WO2004019928A1 (ja) * | 2002-08-30 | 2004-03-11 | Ajinomoto Co., Inc. | 肝疾患治療剤 |
| WO2011021938A3 (en) * | 2009-08-21 | 2011-08-18 | N.V. Nutricia | Regulating the amino acid pool used for the acute-phase protein synthesis |
| CN111821272A (zh) * | 2020-08-11 | 2020-10-27 | 河北科星药业有限公司 | 犬用复方氨基酸肠溶片及其制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4862917A (cs) * | 1971-12-09 | 1973-09-01 | ||
| JPS51118839A (en) * | 1975-02-03 | 1976-10-19 | American Hospital Supply Corp | Amino acid pharmacy for liverish patient dosage |
| JPS5426324A (en) * | 1977-07-28 | 1979-02-27 | Morishita Pharma | Amino acid composition used in treating hepatic meningitis |
-
1979
- 1979-07-03 JP JP8453679A patent/JPS568312A/ja active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4862917A (cs) * | 1971-12-09 | 1973-09-01 | ||
| JPS51118839A (en) * | 1975-02-03 | 1976-10-19 | American Hospital Supply Corp | Amino acid pharmacy for liverish patient dosage |
| JPS5426324A (en) * | 1977-07-28 | 1979-02-27 | Morishita Pharma | Amino acid composition used in treating hepatic meningitis |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5681515A (en) * | 1979-12-07 | 1981-07-03 | Tanabe Seiyaku Co Ltd | Amino acid transfusion |
| JPS58126767A (ja) * | 1982-01-22 | 1983-07-28 | Ajinomoto Co Inc | 肝臓病患者用栄養組成物 |
| JPH0322366B2 (cs) * | 1982-01-22 | 1991-03-26 | Ajinomoto Kk | |
| JPS59500966A (ja) * | 1982-05-17 | 1984-05-31 | ザ・トラステイ−ズ・オブ・コロンビア・ユニヴア−シテイ・イン・ザ・シテイ・オブ・ニユ−・ヨ−ク | 栄養輸液用アミノ酸溶液、その調製法及び使用法 |
| JPH0328403B2 (cs) * | 1982-07-16 | 1991-04-19 | Eezai Kk | |
| JPS5916817A (ja) * | 1982-07-16 | 1984-01-28 | Eisai Co Ltd | アミノ酸輸液 |
| JPH0119363B2 (cs) * | 1982-08-05 | 1989-04-11 | Tanabe Seiyaku Co | |
| JPS5927817A (ja) * | 1982-08-05 | 1984-02-14 | Tanabe Seiyaku Co Ltd | アミノ酸輸液 |
| JPS6483017A (en) * | 1987-09-22 | 1989-03-28 | Morishita Pharma | Amino acid pharmaceutical for patient suffering from hepatic insufficiency |
| JPH0867628A (ja) * | 1994-06-23 | 1996-03-12 | Chugai Pharmaceut Co Ltd | 肝再生用治療剤 |
| EP1044017A4 (en) * | 1998-01-05 | 2005-01-05 | Univ Johns Hopkins | DIETETIC SUPPLEMENT FOR PATIENTS DIALYSIS |
| EP1044017A1 (en) * | 1998-01-05 | 2000-10-18 | John Hopkins University School of Medicine | Supplement for dialysis patients |
| JP2002275059A (ja) * | 2001-03-15 | 2002-09-25 | Inst Of Physical & Chemical Res | 腎機能障害改善用アミノ酸組成物 |
| WO2002074303A1 (fr) * | 2001-03-15 | 2002-09-26 | Riken | Compositions d'acides amines pour ameliorer l'insuffisance renale |
| WO2002074302A1 (fr) * | 2001-03-15 | 2002-09-26 | Riken | Compositions d'acides amines utilisees pour ameliorer l'insuffisance hepatique |
| WO2004019928A1 (ja) * | 2002-08-30 | 2004-03-11 | Ajinomoto Co., Inc. | 肝疾患治療剤 |
| WO2011021938A3 (en) * | 2009-08-21 | 2011-08-18 | N.V. Nutricia | Regulating the amino acid pool used for the acute-phase protein synthesis |
| CN111821272A (zh) * | 2020-08-11 | 2020-10-27 | 河北科星药业有限公司 | 犬用复方氨基酸肠溶片及其制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0116809B2 (cs) | 1989-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1507951A (en) | Amino acid formulations | |
| JPS568312A (en) | Amino acid pharmaceutical preparation | |
| GR3026072T3 (en) | Adolescent dietary composition | |
| SE7907393L (sv) | Aminosyralosning for intravenos neringstillforsel | |
| EP0182356B2 (en) | Nutrient compositions | |
| RU2005138717A (ru) | Способ получения дипептида (варианты) | |
| US5034377A (en) | Aqueous nutrient compositions comprising oligopeptides | |
| CA2280612A1 (en) | Amino acid-sugar composition | |
| CA2244608A1 (en) | Nutritional product with high fat, low carbohydrate and amino acid imbalance | |
| DK0399341T3 (da) | Vandigt præparat til parenteral ernæring | |
| IE39051B1 (en) | New peptides and processes for their manufacture | |
| MX9702275A (es) | Compuestos polipectidicos que contienen d-2 alquiltriptofano capaces de promover la liberacion de hormona del crecimiento. | |
| EP1849466A3 (en) | Infusion fluid for dialysis patients | |
| FR2317917A1 (fr) | Melanges de l-aminoacides et leur utilisation therapeutique | |
| GB1460108A (en) | Pharmaceutical preparations containing aspirin or indomethacin | |
| CA2134380A1 (en) | Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man | |
| Wretlind | The Utilization of D‐Valine for Growth in Rats | |
| ES2132021A1 (es) | Formulas de aminoacidos para personas de la tercera edad y procedimiento para el calculo de las mismas. | |
| JPS5681515A (en) | Amino acid transfusion | |
| JPS57209211A (en) | Antimicrobial composition | |
| GB1496254A (en) | Nutritive infusion solution and its production | |
| GB1131937A (en) | A process for improving and enhancing the palatability of foods, seasonings or beverages | |
| FI901239A0 (fi) | Menetelmä farmaseuttisesti aktiivisen 1,3,4,6,7,8-heksahydro-2H-pyrimido-(1,2-a)-pyrimidiinijohdannaisen valmistamiseksi | |
| WINITZ et al. | Quantitative nutritional and in vivo metabolic studies with water-soluble, chemically defined diets | |
| FR2070149A1 (en) | Hypocalcemiant calcitonin m derivatives |